THURSDAY, Oct. 6, 2022 (HealthDay News) — Fish has been dubbed “brain food,” and a new study suggests that may really be true for middle-aged adults. Researchers found that among more than 2,000 middle-aged people, those with higher blood levels of omega-3 fatty acids performed better on tests of certainContinue Reading
THURSDAY, Oct. 6, 2022 (HealthDay News) — If you have dogs, you probably already know that petting them can give you a lift. Researchers set out to prove that using technology to show what happens in the brain when stroking or sitting next to a dog. They also compared thatContinue Reading
WEDNESDAY, Oct. 5, 2022 (HealthDay News) — Amyloid-beta plaques have long been linked to Alzheimer’s disease, with some scientists theorizing that the plaques actually cause the degenerative brain disease. But a new study suggests that the plaques are actually a symptom of what’s going on in the brain, rather thanContinue Reading
TUESDAY, Oct. 4, 2022 (HealthDay News) — When men become parents, a lot changes in their lives — less sleep and more time devoted to taking care of their children come to mind — but new research now suggests that distinct changes also unfold in a new father’s brain. ResearchersContinue Reading
MONDAY, Oct. 3, 2022 (HealthDay News) — Researchers have discovered another clue as to how some older people stay sharp as a tack into their 80s and beyond: Their brain cells are really big. The study focused on what scientists have dubbed “super-agers” — a select group of elderly adultsContinue Reading
FRIDAY, Sept. 30, 2022 (HealthDay News) – The U.S. Food and Drug Administration on Thursday gave its approval to a new drug for ALS (amyotrophic lateral sclerosis), also known as Lou Gehrig’s disease. But approval of the drug, called Relyvrio, is bound to stir new questions, with some doubting theContinue Reading
THURSDAY, Sept. 29, 2022 (HealthDay News) — Weight-loss surgery can change a person’s life and health, but new research warns it might also come with a slight risk of developing epilepsy. People who had the surgery had a 45% relative increased risk of developing epilepsy, compared with people who didContinue Reading
WEDNESDAY, Sept. 28, 2022 (HealthDay) — Japanese drugmaker Eisai on Wednesday said its experimental drug lecanemab helped slow thinking declines among people in the early stages of Alzheimer’s disease. The findings from a phase 3 clinical trial have yet to be peer-reviewed in any medical journal. But according to aContinue Reading
MONDAY, Sept. 26, 2022 (HealthDay News) — People who work in manufacturing, welding and chemical operations and are exposed to hazardous chemicals may face a higher risk of developing amyotrophic lateral sclerosis (ALS), a new study found. “This study shows that certain occupational settings and exposures increase one’s chances ofContinue Reading
MONDAY, Sept. 26, 2022 (HealthDay News) — Scientists have been looking to the microbiome, and its numerous gut bacteria, as an area of research with plenty of potential for finding connections to various diseases. Now, scientists have found evidence of significant differences between the gut bacteria of individuals who haveContinue Reading